Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
29 July 2022 |
Main ID: |
NCT03423121 |
Date of registration:
|
12/01/2018 |
Prospective Registration:
|
Yes |
Primary sponsor: |
|
Public title:
|
A Trial of Bile Acid Supplementation in Patients With Multiple Sclerosis
|
Scientific title:
|
A Phase 1/2 Trial of Tauroursodeoxycholic Acid Supplementation in Progressive MS Patients |
Date of first enrolment:
|
June 19, 2018 |
Target sample size:
|
58 |
Recruitment status: |
Completed |
URL:
|
https://clinicaltrials.gov/show/NCT03423121 |
Study type:
|
Interventional |
Study design:
|
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Care Provider).
|
Phase:
|
Phase 1/Phase 2
|
|
Countries of recruitment
|
United States
| | | | | | | |
Contacts
|
Name:
|
Pavan Bhargava, MBBS, MD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Johns Hopkins University |
| | |
Key inclusion & exclusion criteria
|
Health Condition(s) or Problem(s) studied
|
Source(s) of Monetary Support
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|